FOLD
Featured PickAmicus Therapeutics, Inc.
Real picks. Real tracking. We bet on one stock daily and show you exactly how it plays out.
AI Confidence Score
82
Entry Price
$14.36
Current Price
$40.22
Total Return
+0.00%
vs SPY
+0.00%
As of Close 2026-03-02
Executive Summary
Amicus Therapeutics (FOLD) serves as the ultimate 'Flight to Quality' shelter, with price action anchored by its pending acquisition by BioMarin Pharmaceutical for $14.50 per share. In a volatile Risk-Off regime, the 'Quiet Storm' signal identifies institutional capital parking in this merger arbitrage spread, treating the stock as a low-beta cash substitute. The steady grind toward the deal price creates a defensive 'Trend Continuation' that insulates investors from broader geopolitical and tariff-driven headwinds.
Technical Context
Setup
Trading just -0.1% from its 52-week high with muted volume (0.7x avg), the stock is pinned tightly to the deal economics, offering a stable yield spread.
Invalidation (Stop)
A close below $14.00 would signal significantly increased risk of the merger deal breaking or regulatory intervention.
Runner-ups
Recent Performance History
22 Total Picks • 65% Win Rate (7d)
| Date | Ticker | Entry | Last | Gain/Loss | 7d | 30d | 60d |
|---|---|---|---|---|---|---|---|
| 2026-02-24 | AES | $16.27 | $14.21 | -12.66% | N/A | N/A | N/A |
| 2026-02-23 | PRA | $24.40 | $24.53 | +0.53% | +0.53% | N/A | N/A |
| 2026-02-20 | ST | $38.35 | $36.85 | -3.91% | -3.91% | N/A | N/A |
| 2026-02-19 | FTI | $61.76 | $67.50 | +9.29% | +9.29% | N/A | N/A |
| 2026-02-18 | FOLD | $14.34 | $14.36 | +0.14% | +0.14% | N/A | N/A |
| 2026-02-17 | ROL | $60.08 | $60.88 | +1.33% | +0.72% | N/A | N/A |
| 2026-02-13 | AES | $16.28 | $14.21 | -12.71% | +1.41% | N/A | N/A |
| 2026-02-12 | PRA | $24.53 | $24.53 | +0.00% | -0.61% | N/A | N/A |
| 2026-02-11 | AES | $16.44 | $14.21 | -13.56% | -0.91% | N/A | N/A |
| 2026-02-10 | RRX | $222.74 | $222.06 | -0.31% | -1.66% | N/A | N/A |
Schema v1.0 | Pipeline v1.2.0